Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only Get Premium

NOTV Inotiv Inc

Price (delayed)

$2.26

Market cap

$77.64M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$3.19

Enterprise value

$507.09M

Bioanalytical Systems, Inc., operating as Inotiv, is a pharmaceutical development company providing contract research services and monitoring instruments to emerging pharmaceutical companies and the world's leading drug development companies and ...

Highlights
NOTV's gross profit is down by 37% YoY but it is up by 2.3% QoQ
Inotiv's EPS has increased by 31% from the previous quarter but it has decreased by 15% YoY
NOTV's gross margin is down by 28% year-on-year
The equity has declined by 24% year-on-year and by 7% since the previous quarter

Key stats

What are the main financial stats of NOTV
Market
Shares outstanding
34.35M
Market cap
$77.64M
Enterprise value
$507.09M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
0.49
Price to sales (P/S)
0.16
EV/EBIT
N/A
EV/EBITDA
89.7
EV/Sales
1.06
Earnings
Revenue
$480.4M
Gross profit
$105.05M
Operating income
-$52.36M
Net income
-$87.47M
EBIT
-$51.06M
EBITDA
$5.65M
Free cash flow
-$52.6M
Per share
EPS
-$3.19
EPS diluted
-$3.19
Free cash flow per share
-$1.55
Book value per share
$4.66
Revenue per share
$14.13
TBVPS
$12.21
Balance sheet
Total assets
$765.97M
Total liabilities
$608.27M
Debt
$448.75M
Equity
$157.69M
Working capital
$58.25M
Liquidity
Debt to equity
2.85
Current ratio
1.5
Quick ratio
0.78
Net debt/EBITDA
75.97
Margins
EBITDA margin
1.2%
Gross margin
21.9%
Net margin
-18.2%
Operating margin
-10.9%
Efficiency
Return on assets
-11.3%
Return on equity
-51.4%
Return on invested capital
-8.2%
Return on capital employed
-7.8%
Return on sales
-10.6%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

NOTV stock price

How has the Inotiv stock price performed over time
Intraday
11.33%
1 week
15.31%
1 month
36.97%
1 year
5.61%
YTD
-45.41%
QTD
2.26%

Financial performance

How have Inotiv's revenue and profit performed over time
Revenue
$480.4M
Gross profit
$105.05M
Operating income
-$52.36M
Net income
-$87.47M
Gross margin
21.9%
Net margin
-18.2%
The operating margin has decreased by 45% YoY but it has increased by 44% from the previous quarter
The operating income is up by 43% since the previous quarter but it has declined by 27% year-on-year
The net margin has contracted by 41% YoY but it has grown by 28% from the previous quarter
NOTV's gross profit is down by 37% YoY but it is up by 2.3% QoQ

Price vs fundamentals

How does NOTV's price correlate with its fundamentals

Growth

What is Inotiv's growth rate over time

Valuation

What is Inotiv stock price valuation
P/E
N/A
P/B
0.49
P/S
0.16
EV/EBIT
N/A
EV/EBITDA
89.7
EV/Sales
1.06
Inotiv's EPS has increased by 31% from the previous quarter but it has decreased by 15% YoY
The P/B is 88% lower than the 5-year quarterly average of 4.0 but 23% higher than the last 4 quarters average of 0.4
The equity has declined by 24% year-on-year and by 7% since the previous quarter
The price to sales (P/S) is 89% less than the 5-year quarterly average of 1.4 but 60% more than the last 4 quarters average of 0.1
Inotiv's revenue has decreased by 13% YoY

Efficiency

How efficient is Inotiv business performance
Inotiv's return on equity has shrunk by 82% YoY but it has increased by 22% QoQ
Inotiv's ROS has plunged by 56% YoY but it has increased by 45% from the previous quarter
The ROIC has soared by 53% QoQ but it is down by 37% YoY
The ROA fell by 33% YoY but it rose by 27% QoQ

Dividends

What is NOTV's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for NOTV.

Financial health

How did Inotiv financials performed over time
The total assets is 26% greater than the total liabilities
NOTV's quick ratio is down by 21% since the previous quarter
The total assets has declined by 6% year-on-year
The debt is 185% more than the equity
The company's debt to equity rose by 38% YoY and by 8% QoQ
The equity has declined by 24% year-on-year and by 7% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.